
Abridge AI Startup Doubles Valuation to $5.3B with $300M Series E Funding
News Summary
Abridge, an AI health tech startup based in Pittsburgh, has successfully doubled its valuation to $5.3 billion just four months after its previous funding round. The company raised $300 million in a Series E round led by Andreessen Horowitz, with continued backing from Khosla Ventures. Abridge, founded by cardiologist Shiv Rao, is a leader in the AI-powered medical scribe market and is known for its integration with Epic Systems, a dominant health record software. The startup’s technology is used by over 150 major health systems in the U.S. Abridge’s recent advancements include expanding into AI-powered medical coding, making it competitive with other startups like CodaMetrix. The company also developed new generative AI tools for various clinical settings, including pediatric and emergency care, and partnered with Wolters Kluwer Health to integrate UpToDate into its AI note-taking tool.




